E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
The pharma secretary said developing a strong component industry is essential for India to cater to the global medical device market.
dineshwori
Tudriqev is approved for use in combination with nivolumab to treat adults with unresectable advanced cutaneous melanoma after progression on an anti-PD-1-based regimen.
imphoenix82
Energenesis and Taiwan Tanabe will collaborate on process technology transfer and manufacturing and controls (CMC) activities to support a potential New Drug Application (NDA) for ENERGI-F703DFU, investigational topical drug for diabetic foot ulcers, in Taiwan.
imphoenix82
The approval makes Yochanra the first drug independently developed in China to address the longstanding global challenge of acquired resistance to FGFR inhibitor therapy in patients with cholangiocarcinoma.
imphoenix82
Unlike a cracked syringe or a mislabeled vial, a software defect can silently affect thousands of devices at once, evade detection until a patient is harmed, and cross borders in the time it takes to push an update.
imphoenix82
A white paper released at India Medical Device 2026 underscores the importance of building a safe, reliable and sustainable maintenance ecosystem for medical equipment across the country.
imphoenix82
Several late-stage pipeline candidates are expected to shape the future of Alzheimer’s disease treatment over the coming years.
imphoenix82
The first commercial Vanquish Water Vapour Ablation (Vanquish System) procedure in New York state was performed on a patient diagnosed with localized prostate cancer.
imphoenix82
Genesis MedTech has overcome a major engineering challenge by integrating 3D imaging, 4K resolution and fluorescence capability into an 8 mm video endoscope, earning CE Mark approval.
imphoenix82
The court found that Ceban infringed Novo Nordisk’s supplementary protection certificate covering semaglutide and ordered it to cease the infringing activities.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
